Loading...

Fojtíková Martina

Martina Fojtíková PhD

Researcher

Research activities

IN VITRO MODELS

METHODS OF MOLECULAR BIOLOGY

TESTING OF ANTIVIRAL ACTIVITY OF NATURAL COMPOUNDS

PRODUCTION OF MONOCLONAL ANTIBODIES

RESEARCH AND DEVELOPMENT OF RECOMBINANT PROTEIN VACCINES

Project involvement

FIT (Pharmacology, Immunotherapy, nanoToxicology)

OP RDE project of the Ministry of Education, Youth and Sports of the Czech Republic – Reg.No. CZ.02.1.01/0.0/0.0/15_003/0000495

CEREBIT (Centre for Recombinant Biotechnologies and Immunotherapeutics)

OP RDE project of the Ministry of Education, Youth and Sports of the Czech Republic – Reg.No. CZ.02.1.01/0.0/0.0/16_025/0007397

Advanced Studies on Pathogenesis of West Nile Fewer towards New Theraputic Strategies

OP RDE project of the Ministry of Education, Youth and Sports of the Czech Republic – Reg.No. CZ.02.2.69/0.0/0.0/16_018/0002665

Education

2012–2019 

PhD in Biochemistry, Faculty of Science, Masaryk University Brno, Czech Republic

2010–2012 

Master degree (Mgr.), Faculty of Science, Palacky University Brno, Czech Republic

2007-2010

Bachelor degree (Bc.), Faculty of Science, Masaryk University Brno, Czech Republic

Internships abroad

2013–2014

King’s College London, UK (5. 3. 2013–13. 2. 2014)

Selected publications

Stefanik M, Valdes JJ, Ezebuo FC, Haviernik J, Uzochukwu IC, Fojtikova M, Salat J, Eyer L, Ruzek D. FDA-Approved Drugs Efavirenz, Tipranavir, and Dasabuvir Inhibit Replication of Multiple Flaviviruses in Vero Cells. Microorganisms. 2020 Apr 20;8(4):599.

Eyer L, Fojtíková M, Nencka R, Rudolf I, Hubálek Z, Ruzek D. Viral RNA-Dependent RNA Polymerase Inhibitor 7-Deaza-2′-C-Methyladenosine Prevents Death in a Mouse Model of West Nile Virus Infection. Antimicrob Agents Chemother. 2019 Feb 26;63(3):e02093-18.

Zouharova D, Lipenska I, Fojtikova M, Kulich P, Neca J, Slany M, Kovarcik K, Turanek-Knotigova P, Hubatka F, Celechovska H, Masek J, Koudelka S, Prochazka L, Eyer L, Plockova J, Bartheldyova E, Miller AD, Ruzek D, Raska M, Janeba Z, Turanek J. Antiviral activities of 2,6-diaminopurine-based acyclic nucleoside phosphonates against herpesviruses: In vitro study results with pseudorabies virus (PrV, SuHV-1). Vet Microbiol. 2016 Feb 29;184:84-93.